IEIH
iShares Evolved U.S. Innovative Healthcare ETF [IEIH] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IEIH Stock Summary
In the News
IEIH Financial details
Company Rating
-
Market Cap
36.79M
Income
232.76M
Revenue
855.27M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
36.48
Forward P/E
-
PEG
-8.08
P/S
0.04
P/B
2.31
P/C
-
P/FCF
0.06
Quick Ratio
2.93
Current Ratio
3.36
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.96
EPS next Y
-
EPS next Q
-
EPS this Y
2.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.15%
Revenue last 5Y
-0.08%
Revenue Q/Q
-3.26%
EPS Q/Q
48%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.04%
Gross Margin
89%
Oper. Margin
42%
Profit Margin
27%
Payout
274%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
34.1-34.1348
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.58
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Market Capitalization 36.79M
- Headquarters US
- IPO Date 2018-03-21
The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.
